Karolina Boman
Malmoe, M 20502, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A novel food-based negative oral contrast agent compared with two conventional oral contrast agents in abdominal CT: a three-arm parallel blinded randomised controlled single-centre trial.
Journal: European radiology experimental
Published: July 06, 2021
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer.
Journal: Biomarker research
Published: July 07, 2020
Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study.
Journal: BMC cancer
Published: January 23, 2020
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens.
Journal: Oncoimmunology
Published: May 15, 2019
Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
Journal: Biomarker research
Published: October 27, 2016
Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.
Journal: Diagnostic pathology
Published: August 22, 2014
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
Journal: BMC urology
Published: November 25, 2013
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
Journal: British journal of cancer
Published: May 09, 2013
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
Journal: BMC urology
Published: January 20, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026